Johnson & Johnson agrees to a $700M settlement over talc-based products' cancer claims without admitting fault.

Johnson & Johnson agreed to pay $700 million to resolve a multi-state investigation into its talc-based products, which were accused of causing cancer. The settlement addressed claims that the company misrepresented the safety of its talc products, which were sold for over a century before being discontinued. Although the settlement has been reached, Johnson & Johnson has not admitted to any wrongdoing. The company faces a substantial number of talc-related lawsuits.

June 11, 2024
121 Articles